Pulse


“Peak Globalization” and the Future of Democracy

The world may be headed toward “peak globalization”. This shift could empower individuals and communities to strengthen democracy, while easing some of the most troublesome aspects of globalization.

FinTech Markets

"Indumbent" Healthcare Thinking: Prices Don't Matter

In a March 29th New York Times article, author Elizabeth Rosenthal chronicles America’s dystopian system for coding and billing medical treatments. Rosenthal concludes that the medical-billing system itself is a primal cause of the nation’s sky-high medical costs,
 

FinTech Chicago

Chicago FinTech executives and developers celebrate, examine, and help create the future of money and finance through a series of events April 24 – 30. As the week approaches, Chicago takes the fifth spot in a new list of global financial technology hubs, based on FinTech innovation research by Deloitte.

Taking the Long View: Financial Sector Regulatory Overhaul and the Trump Administration

Donald Trump vowed as candidate and newly elected president to “do a number” on Dodd Frank, the sweeping 2010 financial services and consumer regulatory reforms and Dodd Frank’s sidekick, the Volcker Rule. While directives by presidential fiat to Trump’s Treasury Secretary, Steven Mnuchin, and regulators to take initial steps, the congressional action needed to overturn Dodd Frank is far less certain. 

Pot Payments

In doing some research on the why legal cannabis businesses cannot get bank accounts, I came across a letter on cannabis business regulation sent last week by the governors of four states to U.S. Attorney General Jeff Sessions and U.S. Secretary of the Treasury Steve Mnuchin. Give pot a chance, the letter essentially asks.

Darwinian Outsourcing: Big Pharma Adapts to Market Realities

Co-authored with Kristin Carey.

Competitive markets drive innovations in business efficiency and strategy. Twenty-five years ago, Big Pharma companies did little outsourcing. Fortified by robust cash flows and high profit margins, they exercised near-total control over drug discovery, testing, approvals, manufacturing and distribution.

Pages